Aluminum Adjuvant Safety

What the evidence shows about claims that aluminum adjuvants cause neurotoxicity or autoimmune conditions.

Verdict: CLAIM NOT SUPPORTED

The Claim

"Aluminum adjuvants in vaccines are neurotoxic and cause autism, Alzheimer's disease, and autoimmune conditions. The aluminum content in vaccines exceeds safe limits for infants."

Evidence Supporting the Claim

1. Aluminum is neurotoxic at high doses: Environmental aluminum exposure is associated with neurological effects in occupational settings.

2. Animal studies: Some animal studies show aluminum can cause neuroinflammation.

Evidence Against the Claim

1. Dose context: The aluminum in vaccines (0.125-0.85 mg per dose) is far below toxic levels. Infants receive more aluminum from breast milk (7-21 mg) or formula (38-70 mg) in the first 6 months than from vaccines (~4 mg total).

2. Extensive use history: Aluminum adjuvants have been used in vaccines for over 90 years with an excellent safety record.

3. Regulatory review: FDA, WHO, and IOM have all concluded aluminum adjuvants are safe at vaccine doses.

VERDICT: CLAIM NOT SUPPORTED

Confidence Level: HIGH

Source Citations

  • • Institute of Medicine. (2012). Adverse Effects of Vaccines: Evidence and Causality.
  • • CDC. Aluminum Adjuvants in Vaccines. cdc.gov

Related Investigations